Alert: Rating Upgrade (11/17/23)-Blueprint Medicines Corp (NASDAQ: BPMC).
Stock Rating Upgrade The Value Trend Rating for Blueprint Medicines Corp (NASDAQ: BPMC) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]